Abstract: Embodiments of the invention relate to somatostatin receptor selective peptides to somatostatin receptor 3, methods for synthesizing the somatostatin analogs and pharmaceutical, and radiopharmaceutical compositions comprising somatostatin receptor 3 analogs, and methods of using such compositions are disclosed for treatment and for diagnosis.
Type:
Application
Filed:
March 3, 2022
Publication date:
May 23, 2024
Applicant:
STARGET PHARMA LTD.
Inventors:
Michel AFARGAN, Eliav BLUM, Yoseph SALITRA